Lexapro for Anxiety: A Psychiatrist Explains How It Works and What to Expect

Lexapro is the brand name for escitalopram, a selective serotonin reuptake inhibitor, or SSRI. SSRIs are the most prescribed class of antidepressants in the United States and the first-line pharmacologic option recommended by clinical practice guidelines for generalized anxiety disorder.

Serotonin is a neurotransmitter, a chemical messenger that nerve cells use to communicate. Among many roles, serotonin helps regulate mood, sleep, appetite, and the brain circuits involved in fear and worry. After a nerve cell releases serotonin to send a signal, transporters quickly pull most of it back into the cell so it can be recycled. SSRIs block that reuptake, leaving more serotonin available in the space between nerve cells. Over weeks, this increased availability triggers downstream changes in receptor sensitivity and improves brain network activity that appear to reduce anxiety symptoms.

Escitalopram is distinct among SSRIs in two ways. First, it is the most selective serotonin reuptake inhibitor available, meaning it acts almost exclusively on the serotonin transporter and has minimal effect on dopamine, norepinephrine, or other neurotransmitter systems. Second, escitalopram binds to a secondary site on the serotonin transporter that strengthens the primary blocking action, a mechanism unique to escitalopram and thought to contribute to its sustained therapeutic effect.

For people with generalized anxiety disorder, this may translate into measurable symptom relief. In pooled data from three placebo-controlled clinical trials involving roughly 850 individuals, escitalopram produced greater improvement in anxiety symptoms than placebo as early as week 1 or 2, and through the full 8-week study period. In a separate double-blind, placebo-controlled study, 68% of individuals on escitalopram met the response criterion of a 50% or greater reduction in Hamilton Anxiety Rating Scale score at week 8, compared with 41% on placebo.

Lexapro is one of the medications most commonly chosen as a starting point for anxiety, but it is not the only first-line option, and it is not the right option for every individual. Clinical guidelines from the American Academy of Family Physicians identify SSRIs and serotonin-norepinephrine reuptake inhibitor (SNRIs) as first-line medications for generalized anxiety disorder; among these, escitalopram and sertraline (Zoloft) are commonly preferred SSRIs, with venlafaxine and duloxetine as comparable SNRI options. Which medication is right for any individual depends on medical history, other prescriptions, prior response to treatment, side-effect sensitivities, and co-occurring conditions. This decision can only be made by a qualified provider after a thorough psychiatric evaluation.

A few practical reasons may lead psychiatrists to consider Lexapro first:

• It is less likely to interact with other medications an individual may already be taking
• People tend to experience milder withdrawal symptoms when stopping Lexapro under their doctor's guidance, compared with some other SSRIs
• It tends to cause fewer unexpected side effects than older antidepressants
• Lexapro is the most precisely targeted SSRI, which can mean fewer effects on other parts of brain function

Other anxiety medications a psychiatrist may consider include:

• Other SSRIs: sertraline (Zoloft), citalopram (Celexa), paroxetine (Paxil), fluoxetine (Prozac)
• SNRIs: venlafaxine (Effexor XR), duloxetine (Cymbalta), often used when comorbid pain is present
• Benzodiazepines: alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), short-term and fast-acting but with risk of tolerance and dependence
• Buspirone (BuSpar): a serotonin-related non-SSRI anxiolytic with a moderately delayed onset of action
• Beta-blockers: propranolol, used off-label for performance anxiety and the physical symptoms of panic
• Gabapentin: used off-label for anxiety, particularly when sleep is disrupted

A psychiatrist weighs the evidence base for each medication, the individual’s profile, and the treatment goal, whether the priority is rapid symptom relief, long-term remission, or a combination, when recommending where to start.

Lexapro and other SSRIs are not rescue medications. Unlike benzodiazepines such as Xanax or Ativan, which can calm acute anxiety within 15 to 60 minutes by temporarily enhancing GABA activity, Lexapro works gradually over weeks through long-term enhancements in serotonin activity that change how signals are processed across brain networks.

The trade-off matters: benzodiazepines provide immediate relief but carry risks of dependence and rebound anxiety with regular use, while SSRIs require patience but work to improve the underlying dysfunctional brain activity causing the anxiety disorder and are generally considered safe for long-term management.

Individuals can typically expect the following timeline on Lexapro:

• Week 1: Some physical effects of anxiety, such as restlessness or sleep disruption, may improve modestly. Side effects like nausea or mild jitteriness are most common during this period.
• Weeks 2 to 4: A clearer reduction in worry, irritability, and somatic anxiety symptoms is often noticeable. Clinical trial data show significant separation from placebo on anxiety rating scales beginning as early as week 1 and continuing through week 8.
• Weeks 4 to 8: Many people who respond to Lexapro reach meaningful improvement by week 8. A 2009 study of escitalopram trials found that individuals showing at least a 20% reduction in anxiety symptoms by week 2 were highly likely to respond by week 8.
• After week 8: For those still experiencing significant symptoms, a psychiatrist may adjust the medication, switch to a different agent, or layer in psychotherapy.

If Lexapro is working, treatment typically continues for at least 6 to 12 months after symptoms are well controlled to reduce the risk of relapse. Lexapro should never be stopped abruptly. Escitalopram is tapered under clinical supervision to minimize discontinuation symptoms.

According to the FDA prescribing information for Lexapro in adults with generalized anxiety disorder, the most common side effects, defined as occurring in approximately 5% or greater of individuals and at least twice the rate of placebo, are:

• Nausea
• Insomnia or sleep disturbance
• Fatigue or drowsiness
• Increased sweating
• Decreased libido
• Anorgasmia and ejaculation delay
• Constipation

Most mild side effects emerge in the first one to two weeks of treatment and resolve as the body adjusts. Sexual side effects often persist throughout treatment and should be discussed with the provider, who may adjust the dose, switch medications, or add another agent.

Rare but serious risks include:

• Increased risk of suicidal thoughts in individuals under 25, particularly in the first weeks of treatment
• Serotonin syndrome, a life-threatening condition caused by excessive serotonin activity, with risk rising when escitalopram is combined with other serotonergic medications or supplements
• Hyponatremia, or low blood sodium
• Abnormal bleeding, particularly when combined with NSAIDs or blood thinners
• QT prolongation, a heart-rhythm disturbance that is dose-dependent
• Activation of mania in those with undiagnosed bipolar disorder

Individuals should tell their provider about all other medications and supplements they take, particularly other antidepressants, monoamine oxidase inhibitors (MAOIs), St. John's Wort, blood thinners, NSAIDs, and any medication that affects heart rhythm. Lexapro should never be combined with MAOIs. When treatment ends, escitalopram is tapered gradually to minimize withdrawal symptoms such as dizziness, flu-like sensations, electric-shock sensations, irritability, and sleep disturbance.

Medication is one tool among several for treating anxiety, and the most durable outcomes typically come from an integrated approach. A psychiatric evaluation establishes the diagnosis, rules out underlying medical contributors, and matches treatment to symptom severity, history, and the individual’s goals.

Psychotherapy. Cognitive behavioral therapy has the strongest evidence base for anxiety disorders, with large effect sizes for generalized anxiety, panic, social anxiety, and OCD. Exposure-based therapies are particularly effective for specific phobias and panic. For many individuals, therapy alone is sufficient; for others, combining therapy with medication produces faster and more durable improvement than either approach alone.

Medication. For moderate to severe anxiety, or when therapy alone has not produced sufficient relief, an SSRI like Lexapro or an SNRI is typically the starting point. Other medications, including buspirone, beta-blockers, gabapentin, and short-term benzodiazepines, may be added or substituted depending on the specific anxiety pattern and how the individual responds.

Lifestyle and adjunctive approaches. Sleep hygiene, regular physical activity, limited caffeine and alcohol, and mindfulness or grounding techniques all support anxiety treatment. They are not substitutes for clinical care in moderate or severe anxiety, but they can meaningfully reduce baseline symptom levels.

If anxiety is interfering with daily life, work, sleep, or relationships, the next step is a psychiatric evaluation. Across nearly 140,000 LifeStance patients with at least moderate anxiety, 79% showed clinically significant improvement in anxiety symptoms through a measurement-informed care model.

A psychiatrist can help determine whether Lexapro is appropriate, which medication best fits the individual, and how to combine therapy and medication into a single plan.

Medication is prescribed only when clinically appropriate. Lexapro is not appropriate for every individual, and treatment decisions should be made with a licensed healthcare provider.